EAGLE PHARMACEUTICALS INC (EGRX) Stock Income Statement
NASDAQ:EGRX - Nasdaq - US2697961082 - Common Stock - Currency: USD
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 257.50M | 316.60M | 171.50M | 187.80M | 195.90M | |||
| Cost Of Goods | 77.80M | 94.90M | 42.20M | 45.50M | 60.90M | |||
| Gross Profit | 179.90M | 221.70M | 129.40M | 142.30M | 135.00M | |||
| Operating Expenses | 137.30M | 119.40M | 126.60M | 109.30M | 113.20M | |||
| Research and Development | 35.60M | 34.10M | 51.30M | 30.80M | 36.80M | |||
| Selling, General, and Administrative Expenses | 102.10M | 85.20M | 75.30M | 78.60M | 76.40M | |||
| Operating Income | 42.40M | 102.40M | 2.80M | 33.00M | 21.80M | |||
| Interest Income/Expense | -12.00M | -12.90M | -7.30M | -2.00M | -500.00K | |||
| Other Income/Expense | 5.10M | -1.70M | 0.00 | -8.30M | 700.00K | |||
| Non Recurring Items | N/A | -26.40M | N/A | 0.00 | 0.00 | |||
| Income Before Taxes | 29.10M | 61.40M | -4.50M | 22.70M | 22.00M | |||
| Income Tax | 17.20M | 25.80M | 4.10M | 10.70M | 7.70M | |||
| Net Income | 12.10M | 35.60M | -8.60M | 12.00M | 14.30M | |||
| EBITDA | 63.02M | 114.43M | 6.56M | 36.54M | 26.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.91 | 2.73 | -0.66 | 0.87 | 1.01 | |||
| Non GAAP EPS | 4.66 | 7.82 | 2.58 | 3.54 | 2.59 | |||
| Statistics | ||||||||
| Gross Profit Margin | 69.86% | 70.03% | 75.45% | 75.77% | 68.91% | |||
| Profit Margin | 4.70% | 11.24% | -5.01% | 6.39% | 7.30% | |||
| Operating Profit Margin | 16.47% | 32.34% | 1.63% | 17.57% | 11.13% | |||
All data in USD